Howard Alliger Net Worth

The estimated Net Worth of Howard Alliger is at least 3.59 百万$ dollars as of 16 June 2015. Howard Alliger owns over 1,000 units of Misonix Inc stock worth over 1,868,416$ and over the last 21 years Howard sold MSON stock worth over 1,717,796$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Howard Alliger MSON stock SEC Form 4 insiders trading

Howard has made over 41 trades of the Misonix Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently Howard sold 1,000 units of MSON stock worth 10,910$ on 16 June 2015.

The largest trade Howard's ever made was selling 95,000 units of Misonix Inc stock on 27 March 2009 worth over 61,750$. On average, Howard trades about 13,960 units every 92 days since 2003. As of 16 June 2015 Howard still owns at least 70,400 units of Misonix Inc stock.

You can see the complete history of Howard Alliger stock trades at the bottom of the page.

What's Howard Alliger's mailing address?

Howard's mailing address filed with the SEC is C/O FRONTIER PHARMACEUTICAL INC, 135 SPAGNOLI RD, MELVILLE, NY, 11747.

Insiders trading at Misonix Inc

Over the last 21 years, insiders at Misonix Inc have traded over 4,371,211$ worth of Misonix Inc stock and bought 1,536,334 units worth 6,620,934$ . The most active insiders traders include Stavros G. Vizirgianakis、Gary Gelman、Michael A Jr Mcmanus. On average, Misonix Inc executives and independent directors trade stock every 29 days with the average trade being worth of 378,885$. The most recent stock trade was executed by Sharon W Klugewicz on 20 May 2020, trading 825 units of MSON stock currently worth 10,032$.

What does Misonix Inc do?

Misonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company's history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients.

Complete history of Howard Alliger stock trades at Misonix Inc

Misonix Inc executives and stock owners

Misonix Inc executives and other stock owners filed with the SEC include:

• Stavros Vizirgianakis,
  President, Chief Executive Officer, Director
• Charles Miner,
  Independent Director
• Paul LaViolette,
  Independent Chairman of the Board
• T Guy Minetti,
  Director
• Patrick A Mc Brayer,
  Director
• John Gildea,
  Director
• Thomas M Patton,
  Director
• Michael L Consilvio,
  VP - Marketing
• Richard A Zaremba,
  Vice President and CFO
• John Joseph Salerno,
  VP, Quality & Regulatory
• Howard Alliger,
  Director
• Daniel Voic,
  VP-R&D and Engineering
• Joseph J Brennan,
  Vice President, Operations
• Gary Gelman,
  10% owner
• Michael A Jr Mcmanus,
  President, CEO
• Michael Koby,
  Director
• Christopher H Wright,
  Vice President - U.S. Sales
• Capital Management, Llc1315...,
  
• Gwendolyn A Watanabe,
  Director
• Jonathan Jay Waggoner,
  SVP, Wound Sales
• Thomas F Oneill,
  Director
• Frank Napoli,
  VP, Operations
• Michael C Ryan,
  SVP, Medical Division
• W Paul Constantine,
  SVP, Strat. Plan. & New Prod.
• Kenneth Coviello,
  V.P - Medical Devices
• Ronald Manna,
  VP-New Prod. Dev. & Reg. Aff.
• Bernhard Berger,
  VP-Industrial/Scientific Prod.
• Allan Richard Staley,
  President
• Linwood A. Staub,
  Sr. VP Wound
• Robert S Ludecker,
  SVP, Global Sales - Marketing
• Joseph P Dwyer,
  Chief Financial Officer
• Pat Beyer,
  Director
• Sharon W Klugewicz,
  Chief Operating Officer